Healthcare provider profile · identity verified

Timothy Patrick Kennard, MD

Family Practice · INDIAN TRAIL, NC · NPI 1306904255

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	736	236
Amlodipine Besylate	Amlodipine Besylate	536	151
Levothyroxine Sodium	Levothyroxine Sodium	349	95
Lisinopril	Lisinopril	347	102
Omeprazole	Omeprazole	305	87
Pantoprazole Sodium	Pantoprazole Sodium	285	78
Gabapentin	Gabapentin	272	80
Losartan Potassium	Losartan Potassium	264	83
Metoprolol Succinate	Metoprolol Succinate	249	76
Tamsulosin Hcl	Tamsulosin Hcl	225	73
Simvastatin	Simvastatin	224	58
Metformin Hcl	Metformin Hcl	215	67
Alprazolam	Alprazolam	209	37
Meloxicam	Meloxicam	199	67
Sertraline Hcl	Sertraline Hcl	177	55
Trazodone Hcl	Trazodone Hcl	165	59
Furosemide	Furosemide	153	57
Fluticasone Propionate	Fluticasone Propionate	145	61
Rosuvastatin Calcium	Rosuvastatin Calcium	136	43
Montelukast Sodium	Montelukast Sodium	134	35
Metoprolol Tartrate	Metoprolol Tartrate	128	34
Tizanidine Hcl	Tizanidine Hcl	121	41
Hydrochlorothiazide	Hydrochlorothiazide	119	36
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	115	19
Pravastatin Sodium	Pravastatin Sodium	106	30
Albuterol Sulfate Hfa	Albuterol Sulfate	101	37
Clopidogrel	Clopidogrel Bisulfate	98	26
Potassium Chloride	Potassium Chloride	98	23
Tramadol Hcl	Tramadol Hcl	98	30
Metformin Hcl Er	Metformin Hcl	97	29
Clonazepam	Clonazepam	92	14
Eliquis	Apixaban	92	27
Carvedilol	Carvedilol	87	26
Bupropion Xl	Bupropion Hcl	84	21
Duloxetine Hcl	Duloxetine Hcl	84	24
Allopurinol	Allopurinol	80	24
Prednisone	Prednisone	78	63
Oxycodone Hcl	Oxycodone Hcl	71	suppressed
Famotidine	Famotidine	69	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	67	21
Glipizide Er	Glipizide	66	19
Benazepril Hcl	Benazepril Hcl	63	17
Lorazepam	Lorazepam	60	14
Jardiance	Empagliflozin	59	19
Synthroid	Levothyroxine Sodium	59	13
Fluoxetine Hcl	Fluoxetine Hcl	58	19
Diazepam	Diazepam	56	12
Venlafaxine Hcl Er	Venlafaxine Hcl	55	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	53	suppressed
Spironolactone	Spironolactone	53	17
Citalopram Hbr	Citalopram Hydrobromide	51	14
Baclofen	Baclofen	49	23
Amitriptyline Hcl	Amitriptyline Hcl	47	12
Meclizine Hcl	Meclizine Hcl	46	12
Zolpidem Tartrate	Zolpidem Tartrate	46	suppressed
Glimepiride	Glimepiride	45	suppressed
Finasteride	Finasteride	42	14
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	42	suppressed
Alendronate Sodium	Alendronate Sodium	41	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	41	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	41	14
Januvia	Sitagliptin Phosphate	40	suppressed
Pregabalin	Pregabalin	40	12
Buspirone Hcl	Buspirone Hcl	38	suppressed
Ozempic	Semaglutide	38	11
Telmisartan	Telmisartan	37	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	35	15
Donepezil Hcl	Donepezil Hcl	34	suppressed
Ramipril	Ramipril	34	suppressed
Atenolol	Atenolol	33	suppressed
Ibuprofen	Ibuprofen	33	12
Cephalexin	Cephalexin	32	23
Methocarbamol	Methocarbamol	32	18
Ondansetron Hcl	Ondansetron Hcl	32	suppressed
Celecoxib	Celecoxib	31	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	31	30
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	31	suppressed
Levemir Flexpen	Insulin Detemir	30	suppressed
Warfarin Sodium	Warfarin Sodium	30	suppressed
Glipizide	Glipizide	29	suppressed
Nystatin	Nystatin	29	15
Hydralazine Hcl	Hydralazine Hcl	28	suppressed
Mounjaro	Tirzepatide	27	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	25	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	24	suppressed
Ezetimibe	Ezetimibe	24	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	19
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	23
Diclofenac Sodium	Diclofenac Sodium	23	suppressed
Linzess	Linaclotide	22	suppressed
Morphine Sulfate Er	Morphine Sulfate	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Cefdinir	Cefdinir	21	21
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Clonidine Hcl	Clonidine Hcl	20	12
Enalapril Maleate	Enalapril Maleate	20	suppressed
Estradiol	Estradiol	20	suppressed
Fenofibrate	Fenofibrate	20	suppressed
Ipratropium Bromide	Ipratropium Bromide	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Tresiba Flextouch U-100	Insulin Degludec	19	suppressed
Trulicity	Dulaglutide	19	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	19	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	18	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Mupirocin	Mupirocin	17	12
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	16	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Klor-Con M20	Potassium Chloride	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Temazepam	Temazepam	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Valsartan	Valsartan	16	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Felodipine Er	Felodipine	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Promethazine Hcl	Promethazine Hcl	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	13
Xarelto	Rivaroxaban	15	suppressed
Xtampza Er	Oxycodone Myristate	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	13	suppressed
Colestipol Hcl	Colestipol Hcl	13	suppressed
Ibandronate Sodium	Ibandronate Sodium	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Torsemide	Torsemide	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Chlorzoxazone	Chlorzoxazone	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Methylphenidate Er	Methylphenidate Hcl	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Uroxatral	Alfuzosin Hcl	12	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Risperidone	Risperidone	11	suppressed
Tiadylt Er	Diltiazem Hcl	11	suppressed
Trueplus Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error